<p>Geneos Wealth Management Inc. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，在第二季度將其在 Houlihan Lokey, Inc.（NYSE:HLI - 免費報告）中的持股比例提高了 63.2%。該公司在此期間額外購買了 12,944 股後，持有該金融服務提供商的 33,430 股股票。根據其最近的 SEC 文件，Geneos Wealth Management Inc. 在 Houlihan Lokey 的持股價值為 6,016,000 美元。</p>
<p>獲取 <strong>Houlihan Lokey</strong> 警報：</p>
<p>其他幾家對沖基金和機構投資者最近也調整了對該公司的持股。托萊多信託公司（Trust Co. of Toledo NA OH）在第二季度新購入了 Houlihan Lokey 的股份，價值約 34,000 美元。布魯克林投資集團（Brooklyn Investment Group）在第一季度新購入了 Houlihan Lokey 的股份，價值約 33,000 美元。戰略財富投資集團（Strategic Wealth Investment Group LLC）在第二季度新購入了 Houlihan Lokey 的股份，價值約 39,000 美元。凱通國際資產管理有限公司（Caitong International Asset Management Co. Ltd）在第一季度將其在 Houlihan Lokey 的持股比例提高了 3,714.3%。凱通國際資產管理有限公司目前持有 267 股該金融服務提供商的股票，價值 43,000 美元，此前在此期間又購買了 260 股。最後，MAI Capital Management 在第二季度將其在 Houlihan Lokey 的持股比例提高了 268.0%。MAI Capital Management 目前持有 368 股該金融服務提供商的股票，價值 66,000 美元，此前在上個季度又購買了 268 股。機構投資者和對沖基金持有該公司 78.07% 的股份。</p>
<h2>分析師設定新目標價</h2>
<p>HLI 最近受到多份分析師報告的關注。Weiss Ratings 在 12 月 8 日的報告中重申了對 Houlihan Lokey 股票的 &#34;買入（b-）&#34; 評級。Zacks Research 在 9 月 29 日的研究報告中將 Houlihan Lokey 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。BMO Capital Markets 在 10 月 3 日的報告中開始覆蓋 Houlihan Lokey，並設定了 &#34;跑贏大盤&#34; 的評級和 230.00 美元的目標價。德意志銀行（Deutsche Bank Aktiengesellschaft）在 10 月 9 日的報告中開始覆蓋 Houlihan Lokey 的股票，給予 &#34;持有&#34; 評級和 210.00 美元的目標價。最後，摩根士丹利在 9 月 8 日的研究報告中將 Houlihan Lokey 的目標價從 192.00 美元提高至 213.00 美元，並給予該公司 &#34;增持&#34; 評級。一位投資分析師對該股票給予了強力買入評級，四位給予了買入評級，五位給予了持有評級。根據 MarketBeat.com 的數據，Houlihan Lokey 目前的共識評級為 &#34;適度買入&#34;，平均目標價為 207.14 美元。</p>
<p><strong>閲讀我們最新的 HLI 股票報告</strong></p>
<h2>Houlihan Lokey 股票下跌 0.4%</h2>
<p>Houlihan Lokey 股票週一開盤價為 179.09 美元。該公司的 50 日簡單移動平均線為 183.99 美元，200 日簡單移動平均線為 188.58 美元。Houlihan Lokey, Inc. 的 52 周低點為 137.99 美元，52 周高點為 211.78 美元。該公司的市值為 125.5 億美元，市盈率為 28.88，貝塔值為 0.95。</p>
<p>Houlihan Lokey（NYSE:HLI - 獲取免費報告）最近在 10 月 30 日發佈了季度財報。該金融服務提供商報告的季度每股收益為 1.84 美元，超出市場共識預期的 1.69 美元，超出幅度為 0.15 美元。Houlihan Lokey 的淨利潤率為 16.62%，股本回報率為 24.17%。該公司季度收入為 6.5945 億美元，而分析師預期為 6.3908 億美元。在去年同期，該公司每股收益為 1.46 美元。與去年同期相比，Houlihan Lokey 本季度的收入增長了 14.7%。分析師預計 Houlihan Lokey, Inc. 本財年每股收益將達到 5.98 美元。</p>
<h2>Houlihan Lokey 宣佈分紅</h2>
<p>該公司最近還宣佈了一項季度分紅，將於 12 月 15 日支付。12 月 1 日的登記投資者將獲得每股 0.60 美元的分紅。這相當於年化分紅 2.40 美元，收益率為 1.3%。除息日為 12 月 1 日。Houlihan Lokey 的分紅支付比率（DPR）目前為 38.71%。</p>
<h2>Houlihan Lokey 的內部交易</h2>
<p>在其他 Houlihan Lokey 的新聞中，董事長 Irwin Gold 於 9 月 16 日星期二出售了 6,811 股該公司的股票。該股票以平均價格 202.75 美元出售，總價值為 1,380,930.25 美元。該交易已在與 SEC 的法律文件中披露，相關文件可通過此鏈接訪問。公司內部人士持有該公司 22.83% 的股份。</p>
<h2>關於 Houlihan Lokey</h2>
<p>（免費報告）</p>
<p>Houlihan Lokey, Inc. 是一家投資銀行公司，提供全球範圍內的併購（M&amp;A）、資本市場、財務重組以及財務和估值諮詢服務。它分為三個部門：企業融資、財務重組和財務與估值諮詢。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Houlihan Lokey</li>
<li>3 只值得購買的醫療保健分紅股票</li>
<li>Dave &amp; Buster’s 的反轉在雙底突破後進入了遊戲</li>
<li>何時出售股票以獲利或虧損</li>
<li>3 只在 10 年期國債利率上升時值得購買的金融股票</li>
<li>如何開始投資於便士股票</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhMSQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhMSQ"/></p>
<p><em>此即時新聞警報由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Houlihan Lokey 嗎？</h2>
<p>在你考慮 Houlihan Lokey 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Houlihan Lokey 並不在名單上。</p>
<p>雖然 Houlihan Lokey 目前在分析師中獲得了中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Geneos Wealth Management Inc. 在第二季度將其在 Houlihan Lokey, Inc. 的持股增加了 63.2%，目前擁有 33,430 股，價值 6,016,000 美元。分析師的評級意見不一，普遍共識為 “適度買入”，平均目標價為 207.14 美元。Houlihan Lokey 報告第三季度每股收益為 1.84 美元，超出預期，並宣佈季度股息為每股 0.60 美元</p>

<p>Geneos Wealth Management Inc. boosted its stake in Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 63.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,430 shares of the financial services provider's stock after buying an additional 12,944 shares during the period. Geneos Wealth Management Inc.'s holdings in Houlihan Lokey were worth $6,016,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Geneos Wealth Management Inc. 在最近向證券交易委員會（SEC）提交的 13F 表格中披露，在第二季度將其在 Houlihan Lokey, Inc.（NYSE:HLI - 免費報告）中的持股比例提高了 63.2%。該公司在此期間額外購買了 12,944 股後，持有該金融服務提供商的 33,430 股股票。根據其最近的 SEC 文件，Geneos Wealth Management Inc. 在 Houlihan Lokey 的持股價值為 6,016,000 美元。</p>
</div><p>Get <strong>Houlihan Lokey</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Houlihan Lokey</strong> 警報：</p>
</div><p>Several other hedge funds and other institutional investors also recently modified their holdings of the company. Trust Co. of Toledo NA OH acquired a new stake in shares of Houlihan Lokey in the 2nd quarter worth about $34,000. Brooklyn Investment Group bought a new position in Houlihan Lokey in the 1st quarter worth about $33,000. Strategic Wealth Investment Group LLC bought a new position in Houlihan Lokey in the 2nd quarter worth about $39,000. Caitong International Asset Management Co. Ltd increased its stake in shares of Houlihan Lokey by 3,714.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 267 shares of the financial services provider's stock valued at $43,000 after purchasing an additional 260 shares during the period. Finally, MAI Capital Management raised its holdings in shares of Houlihan Lokey by 268.0% during the second quarter. MAI Capital Management now owns 368 shares of the financial services provider's stock valued at $66,000 after buying an additional 268 shares during the last quarter. Institutional investors and hedge funds own 78.07% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者最近也調整了對該公司的持股。托萊多信託公司（Trust Co. of Toledo NA OH）在第二季度新購入了 Houlihan Lokey 的股份，價值約 34,000 美元。布魯克林投資集團（Brooklyn Investment Group）在第一季度新購入了 Houlihan Lokey 的股份，價值約 33,000 美元。戰略財富投資集團（Strategic Wealth Investment Group LLC）在第二季度新購入了 Houlihan Lokey 的股份，價值約 39,000 美元。凱通國際資產管理有限公司（Caitong International Asset Management Co. Ltd）在第一季度將其在 Houlihan Lokey 的持股比例提高了 3,714.3%。凱通國際資產管理有限公司目前持有 267 股該金融服務提供商的股票，價值 43,000 美元，此前在此期間又購買了 260 股。最後，MAI Capital Management 在第二季度將其在 Houlihan Lokey 的持股比例提高了 268.0%。MAI Capital Management 目前持有 368 股該金融服務提供商的股票，價值 66,000 美元，此前在上個季度又購買了 268 股。機構投資者和對沖基金持有該公司 78.07% 的股份。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>HLI has been the subject of a number of recent analyst reports. Weiss Ratings reissued a &#34;buy (b-)&#34; rating on shares of Houlihan Lokey in a report on Monday, December 8th. Zacks Research cut Houlihan Lokey from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 29th. BMO Capital Markets assumed coverage on Houlihan Lokey in a report on Friday, October 3rd. They set an &#34;outperform&#34; rating and a $230.00 price target on the stock. Deutsche Bank Aktiengesellschaft began coverage on shares of Houlihan Lokey in a report on Thursday, October 9th. They issued a &#34;hold&#34; rating and a $210.00 price objective for the company. Finally, Morgan Stanley increased their target price on shares of Houlihan Lokey from $192.00 to $213.00 and gave the company an &#34;overweight&#34; rating in a research report on Monday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Houlihan Lokey currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $207.14.</p>
<div class="lb-trans"><p>HLI 最近受到多份分析師報告的關注。Weiss Ratings 在 12 月 8 日的報告中重申了對 Houlihan Lokey 股票的 &#34;買入（b-）&#34; 評級。Zacks Research 在 9 月 29 日的研究報告中將 Houlihan Lokey 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。BMO Capital Markets 在 10 月 3 日的報告中開始覆蓋 Houlihan Lokey，並設定了 &#34;跑贏大盤&#34; 的評級和 230.00 美元的目標價。德意志銀行（Deutsche Bank Aktiengesellschaft）在 10 月 9 日的報告中開始覆蓋 Houlihan Lokey 的股票，給予 &#34;持有&#34; 評級和 210.00 美元的目標價。最後，摩根士丹利在 9 月 8 日的研究報告中將 Houlihan Lokey 的目標價從 192.00 美元提高至 213.00 美元，並給予該公司 &#34;增持&#34; 評級。一位投資分析師對該股票給予了強力買入評級，四位給予了買入評級，五位給予了持有評級。根據 MarketBeat.com 的數據，Houlihan Lokey 目前的共識評級為 &#34;適度買入&#34;，平均目標價為 207.14 美元。</p>
</div><p><strong>Read Our Latest Stock Report on HLI</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 HLI 股票報告</strong></p>
</div><h2>Houlihan Lokey Stock Down 0.4%</h2>
<div class="lb-trans"><h2>Houlihan Lokey 股票下跌 0.4%</h2>
</div><p>Shares of Houlihan Lokey stock opened at $179.09 on Monday. The business has a fifty day simple moving average of $183.99 and a 200-day simple moving average of $188.58. Houlihan Lokey, Inc. has a fifty-two week low of $137.99 and a fifty-two week high of $211.78. The firm has a market cap of $12.55 billion, a price-to-earnings ratio of 28.88 and a beta of 0.95.</p>
<div class="lb-trans"><p>Houlihan Lokey 股票週一開盤價為 179.09 美元。該公司的 50 日簡單移動平均線為 183.99 美元，200 日簡單移動平均線為 188.58 美元。Houlihan Lokey, Inc. 的 52 周低點為 137.99 美元，52 周高點為 211.78 美元。該公司的市值為 125.5 億美元，市盈率為 28.88，貝塔值為 0.95。</p>
</div><p>Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The financial services provider reported $1.84 EPS for the quarter, topping the consensus estimate of $1.69 by $0.15. Houlihan Lokey had a net margin of 16.62% and a return on equity of 24.17%. The firm had revenue of $659.45 million for the quarter, compared to analysts' expectations of $639.08 million. During the same period in the previous year, the business earned $1.46 earnings per share. Houlihan Lokey's revenue for the quarter was up 14.7% compared to the same quarter last year. Analysts anticipate that Houlihan Lokey, Inc. will post 5.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Houlihan Lokey（NYSE:HLI - 獲取免費報告）最近在 10 月 30 日發佈了季度財報。該金融服務提供商報告的季度每股收益為 1.84 美元，超出市場共識預期的 1.69 美元，超出幅度為 0.15 美元。Houlihan Lokey 的淨利潤率為 16.62%，股本回報率為 24.17%。該公司季度收入為 6.5945 億美元，而分析師預期為 6.3908 億美元。在去年同期，該公司每股收益為 1.46 美元。與去年同期相比，Houlihan Lokey 本季度的收入增長了 14.7%。分析師預計 Houlihan Lokey, Inc. 本財年每股收益將達到 5.98 美元。</p>
</div><h2>Houlihan Lokey Announces Dividend</h2>
<div class="lb-trans"><h2>Houlihan Lokey 宣佈分紅</h2>
</div><p>The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, December 1st will be issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Monday, December 1st. Houlihan Lokey's dividend payout ratio (DPR) is presently 38.71%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了一項季度分紅，將於 12 月 15 日支付。12 月 1 日的登記投資者將獲得每股 0.60 美元的分紅。這相當於年化分紅 2.40 美元，收益率為 1.3%。除息日為 12 月 1 日。Houlihan Lokey 的分紅支付比率（DPR）目前為 38.71%。</p>
</div><h2>Insider Transactions at Houlihan Lokey</h2>
<div class="lb-trans"><h2>Houlihan Lokey 的內部交易</h2>
</div><p>In other Houlihan Lokey news, Chairman Irwin Gold sold 6,811 shares of the company's stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $202.75, for a total value of $1,380,930.25. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 22.83% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Houlihan Lokey 的新聞中，董事長 Irwin Gold 於 9 月 16 日星期二出售了 6,811 股該公司的股票。該股票以平均價格 202.75 美元出售，總價值為 1,380,930.25 美元。該交易已在與 SEC 的法律文件中披露，相關文件可通過此鏈接訪問。公司內部人士持有該公司 22.83% 的股份。</p>
</div><h2>About Houlihan Lokey</h2>
<div class="lb-trans"><h2>關於 Houlihan Lokey</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&amp;A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.</p>
<div class="lb-trans"><p>Houlihan Lokey, Inc. 是一家投資銀行公司，提供全球範圍內的併購（M&amp;A）、資本市場、財務重組以及財務和估值諮詢服務。它分為三個部門：企業融資、財務重組和財務與估值諮詢。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Houlihan Lokey</li>
<li>3 Healthcare Dividend Stocks to Buy</li>
<li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li>
<li>When to Sell a Stock for Profit or Loss</li>
<li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li>
<li>How to start investing in penny stocks</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Houlihan Lokey</li>
<li>3 只值得購買的醫療保健分紅股票</li>
<li>Dave &amp; Buster’s 的反轉在雙底突破後進入了遊戲</li>
<li>何時出售股票以獲利或虧損</li>
<li>3 只在 10 年期國債利率上升時值得購買的金融股票</li>
<li>如何開始投資於便士股票</li>
<li>迪士尼的 10 億美元交易將其魔力帶入 OpenAI</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhMSQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HLI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Houlihan Lokey Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Houlihan Lokey 嗎？</h2>
</div><p>Before you consider Houlihan Lokey, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Houlihan Lokey 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Houlihan Lokey 並不在名單上。</p>
</div><p>While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Houlihan Lokey 目前在分析師中獲得了中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Geneos Wealth Management Inc. 增加了其在 Houlihan Lokey, Inc. $HLI 的股份